Bone Marrow TransplantationTransplantation, HomologousBone MarrowGraft vs Host DiseaseHematopoietic Stem Cell TransplantationStem Cell TransplantationBone Marrow CellsTransplantation ConditioningStem CellsTransplantation, AutologousTransplantation ChimeraWhole-Body IrradiationHematopoietic Stem CellsBusulfanLeukemiaTissue DonorsHematologic NeoplasmsAnemia, AplasticBone and BonesGraft SurvivalHistocompatibility TestingRecurrenceRemission InductionHistocompatibilityTreatment OutcomeLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteGraft vs Leukemia EffectLiver TransplantationCyclophosphamideGraft vs Tumor EffectCombined Modality TherapyImmunosuppressive AgentsBone Marrow PurgingLymphocyte DepletionPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation, IsogeneicLymphocyte TransfusionPeripheral Blood Stem Cell TransplantationMice, Inbred C57BLTime FactorsHepatic Veno-Occlusive DiseaseCytomegalovirus InfectionsHematopoiesisMyelodysplastic SyndromesT-LymphocytesRetrospective StudiesSurvival AnalysisAcute DiseaseBone Marrow DiseasesLeukemia, MyeloidTransplantation ImmunologyRadiation ChimeraCell DifferentiationLeukocyte TransfusionImmunosuppressionGraft RejectionKidney TransplantationVidarabineMyeloablative AgonistsHLA AntigensSurvival RateMultiple MyelomaEmbryonic Stem CellsDisease-Free SurvivalHematologic DiseasesLymphoma, Non-HodgkinAntilymphocyte SerumMinor Histocompatibility AntigensGraft vs Host ReactionAntineoplastic Combined Chemotherapy ProtocolsBone Marrow ExaminationNuclear FamilyNeoplasm, ResidualAdult Stem CellsActuarial AnalysisSalvage TherapyChimerismHematopoietic Stem Cell MobilizationCyclosporineCells, CulturedFollow-Up StudiesFlow CytometryColony-Forming Units AssayBone RemodelingChimeraCytarabineMelphalanAntigens, CD34Cord Blood Stem Cell TransplantationGranulocyte Colony-Stimulating FactorSiblingsBone Marrow NeoplasmsHeart TransplantationMesenchymal Stem Cell TransplantationPrognosisSevere Combined ImmunodeficiencyPrimary MyelofibrosisCytomegalovirusMice, Inbred BALB C